403 related articles for article (PubMed ID: 26054568)
21. [The role of vascular endothelial growth factor in angiogenesis and diabetic retinopathy].
Valiatti FB; Crispim D; Benfica C; Valiatti BB; Kramer CK; Canani LH
Arq Bras Endocrinol Metabol; 2011 Mar; 55(2):106-13. PubMed ID: 21584427
[TBL] [Abstract][Full Text] [Related]
22. Role of FAM18B in diabetic retinopathy.
Wang AL; Rao VR; Chen JJ; Lussier YA; Rehman J; Huang Y; Jager RD; Grassi MA
Mol Vis; 2014; 20():1146-59. PubMed ID: 25221423
[TBL] [Abstract][Full Text] [Related]
23. Suppressed expression of tubedown-1 in retinal neovascularization of proliferative diabetic retinopathy.
Gendron RL; Good WV; Adams LC; Paradis H
Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):3000-7. PubMed ID: 11687548
[TBL] [Abstract][Full Text] [Related]
24. Poly(ADP-ribose) polymerase inhibitors counteract diabetes- and hypoxia-induced retinal vascular endothelial growth factor overexpression.
Obrosova IG; Minchenko AG; Frank RN; Seigel GM; Zsengeller Z; Pacher P; Stevens MJ; Szabó C
Int J Mol Med; 2004 Jul; 14(1):55-64. PubMed ID: 15202016
[TBL] [Abstract][Full Text] [Related]
25. Suppression of protein kinase C-ζ attenuates vascular leakage via prevention of tight junction protein decrease in diabetic retinopathy.
Song HB; Jun HO; Kim JH; Yu YS; Kim KW; Kim JH
Biochem Biophys Res Commun; 2014 Jan; 444(1):63-8. PubMed ID: 24434146
[TBL] [Abstract][Full Text] [Related]
26. Role of endocannabinoids in the progression of diabetic retinopathy.
Behl T; Kaur I; Kotwani A
Diabetes Metab Res Rev; 2016 Mar; 32(3):251-9. PubMed ID: 26379208
[TBL] [Abstract][Full Text] [Related]
27. Ethanol extract of Dendrobium chrysotoxum Lindl ameliorates diabetic retinopathy and its mechanism.
Gong CY; Yu ZY; Lu B; Yang L; Sheng YC; Fan YM; Ji LL; Wang ZT
Vascul Pharmacol; 2014 Sep; 62(3):134-42. PubMed ID: 24846859
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological approach to diabetic retinopathy.
De La Cruz JP; González-Correa JA; Guerrero A; de la Cuesta FS
Diabetes Metab Res Rev; 2004; 20(2):91-113. PubMed ID: 15037985
[TBL] [Abstract][Full Text] [Related]
29. Effects of tenascin-C on normal and diabetic retinal endothelial cells in culture.
Castellon R; Caballero S; Hamdi HK; Atilano SR; Aoki AM; Tarnuzzer RW; Kenney MC; Grant MB; Ljubimov AV
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2758-66. PubMed ID: 12147613
[TBL] [Abstract][Full Text] [Related]
30. Indications of lymphatic endothelial differentiation and endothelial progenitor cell activation in the pathology of proliferative diabetic retinopathy.
Loukovaara S; Gucciardo E; Repo P; Vihinen H; Lohi J; Jokitalo E; Salven P; Lehti K
Acta Ophthalmol; 2015 Sep; 93(6):512-23. PubMed ID: 25899460
[TBL] [Abstract][Full Text] [Related]
31. The Oxidative Stress and Mitochondrial Dysfunction during the Pathogenesis of Diabetic Retinopathy.
Wu MY; Yiang GT; Lai TT; Li CJ
Oxid Med Cell Longev; 2018; 2018():3420187. PubMed ID: 30254714
[TBL] [Abstract][Full Text] [Related]
32. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.
Aiello LP; Avery RL; Arrigg PG; Keyt BA; Jampel HD; Shah ST; Pasquale LR; Thieme H; Iwamoto MA; Park JE
N Engl J Med; 1994 Dec; 331(22):1480-7. PubMed ID: 7526212
[TBL] [Abstract][Full Text] [Related]
33. Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy.
Wan TT; Li XF; Sun YM; Li YB; Su Y
Biomed Pharmacother; 2015 Aug; 74():145-7. PubMed ID: 26349976
[TBL] [Abstract][Full Text] [Related]
34. The pathogenesis of diabetic retinopathy: old concepts and new questions.
Cai J; Boulton M
Eye (Lond); 2002 May; 16(3):242-60. PubMed ID: 12032713
[TBL] [Abstract][Full Text] [Related]
35. Capacity of aflibercept to counteract VEGF-stimulated abnormal behavior of retinal microvascular endothelial cells.
Deissler HL; Lang GK; Lang GE
Exp Eye Res; 2014 May; 122():20-31. PubMed ID: 24631334
[TBL] [Abstract][Full Text] [Related]
36. Pathological Perturbations in Diabetic Retinopathy: Hyperglycemia, AGEs, Oxidative Stress and Inflammatory Pathways.
Sahajpal NS; Goel RK; Chaubey A; Aurora R; Jain SK
Curr Protein Pept Sci; 2019; 20(1):92-110. PubMed ID: 30264677
[TBL] [Abstract][Full Text] [Related]
37. Vascular endothelial growth factor and its receptors in control and diabetic rat eyes.
Gilbert RE; Vranes D; Berka JL; Kelly DJ; Cox A; Wu LL; Stacker SA; Cooper ME
Lab Invest; 1998 Aug; 78(8):1017-27. PubMed ID: 9714188
[TBL] [Abstract][Full Text] [Related]
38. [The role of protein kinase C in the pathophysiology of diabetic retinopathy].
Lang GE; Kampmeier J
Klin Monbl Augenheilkd; 2002 Nov; 219(11):769-76. PubMed ID: 12494366
[TBL] [Abstract][Full Text] [Related]
39. Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy.
Hogeboom van Buggenum IM; Polak BC; Reichert-Thoen JW; de Vries-Knoppert WA; van Hinsbergh VW; Tangelder GJ
Diabetologia; 2002 Feb; 45(2):203-9. PubMed ID: 11935151
[TBL] [Abstract][Full Text] [Related]
40. Lenalidomide, an anti-tumor drug, regulates retinal endothelial cell function: Implication for treating ocular neovascular disorder.
Dong LF; Yao J; Wang XQ; Shan K; Yang H; Yan B; Jiang Q
Biochem Biophys Res Commun; 2015 Oct; 465(4):678-84. PubMed ID: 26255966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
